tiprankstipranks
ACADIA Pharmaceuticals Inc. (GB:0A4W)
:0A4W
UK Market

ACADIA Pharmaceuticals (0A4W) Income Statement

Compare
0 Followers

ACADIA Pharmaceuticals Income Statement

Last quarter (Q4 2024), ACADIA Pharmaceuticals's total revenue was $259.60M, an increase of 12.36% from the same quarter last year. In Q4, ACADIA Pharmaceuticals's net income was $143.74M. See ACADIA Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 957.80M$ 726.44M$ 517.24M$ 484.14M$ 441.75M
Gross Profit
$ 875.96M$ 680.71M$ 507.07M$ 465.00M$ 421.20M
Operating Expenses
$ 645.16M$ 754.09M$ 730.66M$ 635.44M$ 707.79M
Depreciation and Amortization
$ 15.88M$ 5.55M$ 2.03M$ 3.34M$ 2.93M
EBITDA
$ 100.16M$ -67.83M$ -221.57M$ -167.09M$ -286.59M
Operating Income
$ 230.79M$ -73.38M$ -223.60M$ -170.44M$ -286.59M
Other Income/Expenses
$ 27.28M$ 22.34M$ 10.15M$ 2.92M$ 5.61M
Pretax Income
$ 258.07M$ -51.04M$ -213.44M$ -167.52M$ -280.97M
Net Income
$ 226.45M$ -61.29M$ -215.97M$ -167.87M$ -281.58M
Per Share Metrics
Basic EPS
$ 1.37$ -0.37$ -1.34$ -1.05$ -1.79
Diluted EPS
$ 1.36$ -0.37$ -1.34$ -1.05$ -1.79
Weighted Average Shares Outstanding
165.72M 163.82M 161.68M 160.49M 157.33M
Weighted Average Shares Outstanding (Diluted)
166.36M 163.82M 161.68M 160.49M 157.33M
Currency in USD

ACADIA Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis